-
-
-
-
-
-
-
Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates
-
-
-
-
-
-
-
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
-
-
-
-
-
-
-
Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates
-
-
-
-
-
-
-
Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
-
1,202,049 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


